Recruiting

Self-Efficacy as Predictor of Treatment Outcome in Eating Disorders

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
Study Aim

This observational study aims to understand how self-efficacy, or belief in one's own abilities, can predict the outcome of treatment in individuals with eating disorders, measured using the Eating Disorder-15 (ED-15) self-report questionnaire.

What is being collected

Data Collection

Collected from today forward - Prospective
Who is being recruted

Feeding and Eating Disorders+2

+ Mental Disorders

+ Signs and Symptoms

Over 18 Years
+3 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Cohort

Tracking disease incidence in order to identify risk factors and understand disease progression over time.
Observational
Study Start: March 2023
See protocol details

Summary

Principal SponsorAltrecht
Study ContactAlberte Jansingh, MScMore contacts
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: March 28, 2023

Actual date on which the first participant was enrolled.

This study is about eating disorders (EDs), which are serious mental health conditions that negatively impact eating habits, health, and overall quality of life. The goal of this research is to understand if a person's self-efficacy, or belief in their ability to successfully manage their disorder, at the beginning of treatment can predict how well they will respond to therapy. This is important because while there are several proven treatments for EDs, their success rates are not as high as hoped. By identifying factors that might improve treatment outcomes, care for individuals with EDs could be enhanced. The study focuses on patients undergoing CBT-T, a brief form of cognitive behavioral therapy for eating disorders like bulimia nervosa, binge eating disorder, and other specified feeding or eating disorder. During the study, participants will complete a questionnaire called the ED-15 at various stages of their treatment. This questionnaire measures changes in eating disorder pathology, or the severity of ED symptoms. The study also examines if self-efficacy, self-esteem, and autonomous motivation are linked. These concepts will be measured at the start of treatment to see if they are positively correlated. The primary hypothesis is that higher levels of self-efficacy will lead to a more positive treatment outcome, as measured by lower levels of eating disorder pathology. The secondary hypotheses are that self-efficacy will improve during treatment, and that autonomous motivation, self-esteem, and self-efficacy will be positively correlated.

Official TitleDoes Self-Efficacy at the Start of Treatment Predict Treatment Outcome in Patients With EDs?
NCT06790030
Principal SponsorAltrecht
Study ContactAlberte Jansingh, MScMore contacts
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

50 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Cohort

These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Feeding and Eating DisordersMental DisordersSigns and SymptomsSigns and Symptoms, DigestivePathological Conditions, Signs and Symptoms

Criteria

3 exclusion criteria prevent from participating
Intellectual disability according to the Diagnostic Statistical Manual (DSM-5) or an IQ below 80

Inability to speak or read Dutch

Patients treated under a legal act

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Recruiting

Altrecht Eatings Disorders Rintveld

Zeist, NetherlandsOpen Altrecht Eatings Disorders Rintveld in Google Maps
Recruiting
One Study Center